Open AccessLong-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile
Author(s) -
Monica Zolezzi,
Rawan Abouelhassan,
Yassin Eltorki,
Peter Haddad,
Mahtab Noorizadeh
Publication year - 2021
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s309768
Subject(s) - medicine , adverse effect , injection site , clinical trial , incidence (geometry) , optics , physics
Long acting injectable (LAI) antipsychotics are commonly used in the treatment of schizophrenia to improve adherence and clinical outcomes. Concerns have been reported in relation to their non-systemic or injection site adverse effect profile. As such, this study aims to review and evaluate all evidence reporting injection site adverse effects with LAI antipsychotics.